Back
Columbia Research Enhanced Value ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
60
REVS
Columbia Research Enhanced Value ETF
Last Price:
23.26
Seasonality Move:
-1.13%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
34.89
Seasonality Move:
0.54%
Buy
60
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?
- The current Columbia Research Enhanced Value ETF [REVS] share price is $23.15. The Score for REVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- REVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $34.87. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
REVS Stock Price Chart
What is Columbia Research Enhanced Value ETF's stock price today?
-
The Columbia Research Enhanced Value ETF share price today is $23.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $34.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
REVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 47.55 | Sell |
Chaikin Money Flow: | 1284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.06 - 23.3) | Sell |
Bollinger Bands (100): | (22.7 - 23.58) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.22 | Buy |
Relative Strength Index (14 RSI): | 86.65 | Buy |
Chaikin Money Flow: | 484372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.64 - 26.62) | Buy |
Bollinger Bands (100): | (17.72 - 23.42) | Buy |
REVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.21 | Sell |
20-day SMA: | 23.16 | Sell |
50-day SMA: | 23.27 | Sell |
200-day SMA: | 22.05 | Buy |
8-day EMA: | 23.21 | Sell |
20-day EMA: | 23.21 | Sell |
50-day EMA: | 23.2 | Sell |
200-day EMA: | 22.35 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.37 | Buy |
20-day SMA: | 22.43 | Buy |
50-day SMA: | 21.05 | Buy |
200-day SMA: | 15.33 | Buy |
8-day EMA: | 28.7 | Buy |
20-day EMA: | 24.43 | Buy |
50-day EMA: | 21.77 | Buy |
200-day EMA: | 16.75 | Buy |
Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Columbia Research Enhanced Value ETF Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |